Sage Journals: Discover world-class research

Abstract

Purpose

To compare and evaluate the results of phacoemulsification surgery involving and not involving an ophthalmic-viscosurgical-device (OVD).

Methods

A prospective, randomized controlled trial included 60 eyes of 60 patients scheduled to receive phacoemulsification surgery. In order of presentation, patients were randomized into two groups to undergo different surgical techniques: the OVD-free group (n = 30) and the OVD group (n = 30). Each patient’s operating time, total ultrasonography (U/S) time, cumulative dissipated energy (CDE), aspiration time, and volume of balanced salt solution (BSS) aspirated were recorded. At 1 day, 1 week, and 1 and 3 months postoperation, measurements of endothelial cell density (ECD) and intraocular pressure (IOP), were taken and compared between the groups.

Results

Total U/S time (p = .567) and CDE (p = .168) were similar between the groups. In the OVD group, operating time (p = .011), aspiration time (p < .001), and volume of BSS aspirated (p < .001) were greater than in the OVD-free group. The change in ECD between the groups was not statistically significant at all visits (p = .433, p = .147, p = .379, p = .534; respectively). Although IOP increased in the OVD group at 1 day postoperation (p = .001), no difference emerged between the groups at 3 months postoperation (p = .121).

Conclusion

Phacoemulsification surgery without an OVD took less time than with the OVD and caused no significant loss in ECD. Surgeons concerned about elevated IOP following cataract surgery should apply the OVD-free method.

Keywords

endothelial cell density intraocular pressure phacoemulsification viscosurgical device

Get full access to this article

View all access options for this article.

References

Soscia

Howard

Olson

. Bimanual phacoemulsification through 2 stab incisions. A wound-temperature study. J Cataract Refract Surg 2002; 28: 1039–1043.

Pape

Balazs

. The use of sodium hyaluronate (Healon) in human anterior segment surgery. Ophthalmology 1980; 87: 699–705.

Malvankar-Mehta

Subramanian

, et al. Impact of ophthalmic viscosurgical devices in cataract surgery. J Ophthalmol 2020; 2020: 7801093.

Nissen

Jørgensen

Nørregaard

, et al. The effect of orally administered glycerol on anterior chamber depth during cataract surgery in eyes with narrow anterior chambers. Acta Ophthalmol Epub ahead of print July 2020. DOI: 10.1111/aos.14543

Morgan

Skuta

. Viscoelastic-related glaucomas. Semin Ophthalmol 1994; 9: 229–234.

Arshinoff

Albiani

Taylor-Laporte

. Intraocular pressure after bilateral cataract surgery using Healon, Healon5, and Healon GV. J Cataract Refract Surg 2002; 28: 617–625.

Altıntaş

Ciritoğlu

BeyazyıldıZ

, et al. Toxic anterior segment syndrome outbreak after cataract surgery triggered by viscoelastic substance. Middle East Afr J Ophthalmol 2017; 24: 43–47.

Kiss

Findl

Menapace

, et al. Corneal endothelial cell protection with a dispersive viscoelastic material and an irrigating solution during phacoemulsification: low-cost versus expensive combination. J Cataract Refract Surg 2003; 29: 733–740.

Sallet

. Viscoless microincision cataract surgery. Clin Ophthalmol 2008; 2: 717–721.

10.

Blumenthal

Assia

Chen

, et al. Using an anterior chamber maintainer to control intraocular pressure during phacoemulsification. J Cataract Refract Surg 1994; 20: 93–96.

11.

Schipper

. Implantation of a Staar silicone intraocular lens with the anterior chamber maintainer. J Cataract Refract Surg 1996; 22: 23–26.

12.

Nayak

Jain

. Comparison of corneal endothelial cell loss during phacoemulsification using continuous anterior chamber infusion versus those using ophthalmic viscosurgical device: randomized controlled trial. Indian J Ophthalmol 2009; 57: 99–103.

13.

Bianchi

. Phacoemulsification cataract surgery without viscoelastic substance. JOJ Ophthalmol Epub ahead of print 2017; 4. DOI: 10.19080/JOJO.2017.04.555646

14.

Bardoloi

Sarkar

Pilania

, et al. Pure phaco: phacoemulsification without ophthalmic viscosurgical devices. J Cataract Refract Surg 2020; 46: 174–178.

15.

Schargus

Suckert

Schultz

, et al. Femtosecond laser-assisted cataract surgery without OVD: a prospective intraindividual comparison. J Refract Surg 2015; 31: 146–152.

16.

Özcura

Çevik

. Hydroimplantation versus viscoimplantation: comparison of intraocular lens implantation with and without ophthalmic viscoelastic device in phacoemulsification. Rom J Ophthalmol 2018; 62: 282–287.

17.

Tak

. Hydroimplantation: foldable intraocular lens implantation without an ophthalmic viscosurgical device. J Cataract Refract Surg 2010; 36: 377–379.

18.

Chylack

LTJ

Wolfe

Singer

, et al. The lens opacities classification system III: the longitudinal study of cataract study group. Arch Ophthalmol (Chicago, Ill 1960) 1993; 111: 831–836.

19.

Park

Y-G

Chung

S-H

Joo

C-K

. Comparison of microcoaxial with standard clear corneal incisions in torsional handpiece cataract surgery. Ophthalmol J Int D’ophtalmologie Int J Ophthalmol Zeitschrift fur Augenheilkd 2012; 227: 55–59.

20.

Czajka

Frajdenberg

Johansson

. Comparison of 1.8-mm incision versus 2.75-mm incision cataract surgery in combined phacoemulsification and 23-gauge vitrectomy. Acta Ophthalmol 2016; 94: 507–513.

21.

Jun

Berdahl

Kuo

, et al. Corneal wound architecture and integrity after torsional and mixed phacoemulsification: evaluation of standard and microincisional coaxial techniques. Ophthalmic Surgery, Lasers Imaging Off J Int Soc Imaging Eye 2010; 41: 128–134.

22.

Park

Yum

Kim

, et al. Comparison of phaco-chop, divide-and-conquer, and stop-and-chop phaco techniques in microincision coaxial cataract surgery. J Cataract Refract Surg 2013; 39: 1463–1469.

23.

Kugu

Erdogan

Sahin Sevim

, et al. A clinical comparison of safety and efficacy in phacoemulsification with versus without ophthalmic viscoelastic device. Semin Ophthalmol 2015; 30: 96–100.

24.

Schulze

Bertelmann

Manojlovic

, et al. Changes in corneal endothelium cell characteristics after cataract surgery with and without use of viscoelastic substances during intraocular lens implantation. Clin Ophthalmol 2015; 9: 2073–2080.

25.

O’Brien

Fitzpatrick

Kilmartin

, et al. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg 2004; 30: 839–843.

26.

Long-term corneal endothelial cell loss after cataract surgery. Results of a randomized controlled trial. Oxford Cataract Treatment and Evaluation Team (OCTET). Arch Ophthalmol (Chicago, Ill 1960) 1986; 104: 1170–1175.

27.

Taşkın

Aslan

. Effects of phacoemulsification with versus without viscoelastic devices on surgical outcomes. Int Ophthalmol 2018; 38: 5–10.

28.

Das

Nanaiah

Kummelil

, et al. Effect of fluidics on corneal endothelial cell density, central corneal thickness, and central macular thickness after phacoemulsification with torsional ultrasound. Indian J Ophthalmol 2015; 63: 641–644.

29.

Baradaran-Rafii

Rahmati-Kamel

Eslani

, et al. Effect of hydrodynamic parameters on corneal endothelial cell loss after phacoemulsification. J Cataract Refract Surg 2009; 35: 732–737.

30.

Schriefl

Stifter

Menapace

. Impact of low versus high fluidic settings on the efficacy and safety of phacoemulsification. Acta Ophthalmol 2014; 92: e454–e457.

31.

Kim

. Intraocular inflammation of denatured viscoelastic substance in cases of cataract extraction and lens implantation. J Cataract Refract Surg 1987; 13: 537–542.

32.

Buchen

Calogero

Hilmantel

, et al. Detecting endotoxin contamination of ophthalmic viscosurgical devices: intracameral versus intravitreal assays in rabbits. Ophthalmology 2012; 119: e11–e18.

33.

Althomali

. Viscoelastic substance in prefilled syringe as an etiology of Toxic Anterior Segment Syndrome. Cutan Ocul Toxicol 2016; 35: 237–241.

34.

Lee

Choy

Park

. Comparison of OVD and BSS for maintaining the anterior chamber during IOL implantation. Korean J Ophthalmol 2011; 25: 15–21.

35.

Shingleton

Mitrev P

. Anterior chamber maintainer versus viscoelastic material for intraocular lens implantation: case-control study. J Cataract Refract Surg 2001; 27: 711–714.

36.

Sholohov

Levartovsky

. Retained ophthalmic viscosurgical device material in the capsular bag 6 months after phacoemulsification. J Cataract Refract Surg 2005; 31: 627–629.

37.

Hildebrand

Wickremasinghe

Tranos

, et al. Efficacy of anterior chamber decompression in controlling early intraocular pressure spikes after uneventful phacoemulsification. J Cataract Refract Surg 2003; 29: 1087–1092.

38.

Kim

M-W

Brauner

, et al. Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery. Eye (Lond) 2011; 25: 929–936.

39.

Martinez-de-la-Casa

Ruiz-Calvo

Saenz-Frances

, et al. Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci 2012; 53: 6214–6218.

40.

Vision 2020: the cataract challenge. Community Eye Heal 2000; 17–19.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

The safety and efficacy of phacoemulsification surgery in uncomplicated cataracts with and without an ophthalmic-viscosurgical-device

Abstract

Purpose

Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material